Arcutis Biotherapeutics (ARQT) Other Non-Current Assets (2019 - 2026)

Arcutis Biotherapeutics' Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $2.3 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 285.23% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $2.3 million (up 285.23% YoY), while the FY2025 annual figure was $1.4 million, up 138.09% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $2.3 million, up from $1.4 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $2.3 million in Q1 2026, with the low at $78000.0 in Q1 2022.
• The 5-year median for Other Non-Current Assets is $596000.0 (2023), against an average of $592000.0.
• The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets soared 664.1% in 2023, then dropped 0.17% in 2024.
• Arcutis Biotherapeutics' Other Non-Current Assets stood at $78000.0 in 2022, then jumped by 664.1% to $596000.0 in 2023, then changed by 0.0% to $596000.0 in 2024, then jumped by 138.09% to $1.4 million in 2025, then jumped by 61.8% to $2.3 million in 2026.
• Business Quant data shows ARQT's Other Non-Current Assets at $2.3 million in Q1 2026, $1.4 million in Q4 2025, and $596000.0 in Q3 2025.